Published • loading... • Updated
ESMO26: Moderna, MSD Reveal Cancer Jab Data Early After Leak
The vaccine and Keytruda cut recurrence or death risk by 42%, and ESMO launched an investigation after the embargo breach.
Summary by Pharmaphorum
4 Articles
4 Articles
The medical company stated that there was a violation of the agreement prohibiting the early disclosure of the data.
Results of a study on an experimental vaccine against cancer, developed by the modern and merck pharmaceutical companies, were reported in advance on social networks and caused repercussions on the market.The data indicate that the immunizer reduced the risk of dissemination of melanoma by 38% and the risk of recurrence of disease or death by 42%, compared to the standard treatment of immunotherapy.The disclosure occurred before the official pre…
Coverage Details
Total News Sources4
Leaning Left0Leaning Right0Center2Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
